Clough Capital Partners’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-19,110
| Closed | -$8.31M | – | 124 |
|
2025
Q1 | $8.31M | Buy |
+19,110
| New | +$8.31M | 1.04% | 39 |
|
2024
Q4 | – | Sell |
-32,284
| Closed | -$16.8M | – | 133 |
|
2024
Q3 | $16.8M | Buy |
32,284
+6,375
| +25% | +$3.32M | 1.72% | 18 |
|
2024
Q2 | $14M | Buy |
25,909
+2,595
| +11% | +$1.41M | 1.53% | 19 |
|
2024
Q1 | $12.1M | Buy |
23,314
+19,115
| +455% | +$9.91M | 1.33% | 31 |
|
2023
Q4 | $1.98M | Sell |
4,199
-801
| -16% | -$378K | 0.22% | 77 |
|
2023
Q3 | $2.18M | Hold |
5,000
| – | – | 0.23% | 89 |
|
2023
Q2 | $2.22M | Hold |
5,000
| – | – | 0.22% | 110 |
|
2023
Q1 | $2.3M | Hold |
5,000
| – | – | 0.25% | 102 |
|
2022
Q4 | $2.56M | Buy |
+5,000
| New | +$2.56M | 0.26% | 83 |
|
2021
Q3 | – | Sell |
-33,725
| Closed | -$12.9M | – | 122 |
|
2021
Q2 | $12.9M | Sell |
33,725
-41,250
| -55% | -$15.7M | 0.7% | 55 |
|
2021
Q1 | $26.9M | Buy |
+74,975
| New | +$26.9M | 1.2% | 17 |
|
2019
Q2 | – | Sell |
-66,458
| Closed | -$19.1M | – | 116 |
|
2019
Q1 | $19.1M | Buy |
66,458
+30,735
| +86% | +$8.82M | 1.67% | 19 |
|
2018
Q4 | $9.38M | Buy |
+35,723
| New | +$9.38M | 1.1% | 28 |
|
2015
Q2 | – | Sell |
-44,780
| Closed | -$6.91M | – | 209 |
|
2015
Q1 | $6.91M | Sell |
44,780
-48,700
| -52% | -$7.52M | 0.23% | 119 |
|
2014
Q4 | $11.7M | Buy |
93,480
+45,550
| +95% | +$5.72M | 0.42% | 88 |
|
2014
Q3 | $5.73M | Sell |
47,930
-148,200
| -76% | -$17.7M | 0.21% | 111 |
|
2014
Q2 | $21.1M | Sell |
196,130
-113,670
| -37% | -$12.2M | 0.67% | 60 |
|
2014
Q1 | $30.8M | Buy |
309,800
+52,500
| +20% | +$5.23M | 0.96% | 34 |
|
2013
Q4 | $23.8M | Sell |
257,300
-34,400
| -12% | -$3.18M | 0.78% | 46 |
|
2013
Q3 | $24.4M | Buy |
291,700
+88,800
| +44% | +$7.42M | 0.76% | 45 |
|
2013
Q2 | $16.6M | Buy |
+202,900
| New | +$16.6M | 0.55% | 63 |
|